Delivery Order SPE2DR25D1053-SPE2DR26FT957
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $10,560.80 to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets (30-count units) on August 4, 2025, with an ultimate completion date of August 5, 2025. This firm fixed-price, non-set-aside contract represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a delivery order valued at approximately $13,969 to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (30-count units) on September 18, 2025, with an ultimate completion date of September 19, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement executed under AmerisourceBergen's existing indefinite delivery contract vehicle with DLA Troop Support Medical. The performance location is AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Vemlidy 25 mg tablets (30-count units) under a firm fixed-price contract valued at $12,049.24. This is a non-set-aside competitive award with an ultimate completion date of September 19, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $26,302.30 to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets (30-count units). Issued on May 6, 2025, with an ultimate completion date of May 7, 2025, this firm fixed-price delivery order represents a non-competitive set-aside award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Vemlidy is an antiviral medication used in the treatment of...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,642.26 to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets (30-count unit). This firm fixed-price contract, awarded on August 29, 2025, with completion targeted for September 2, 2025, represents a non-competitive delivery order issued under a larger indefinite delivery vehicle. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Vemlidy is an...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $44,079.30 to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets (30-count units) on November 12, 2025, with an ultimate completion date of November 13, 2025. This firm fixed-price contract was competitively awarded with no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Vemlidy is an antiviral medication used in the treatment of chronic...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,139.66 to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets (30-count units) on October 29, 2025, with an ultimate completion date of October 30, 2025. This competitively awarded, firm fixed-price delivery order was issued without a set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract action under...
- The Defense Logistics Agency awarded a delivery order valued at $5,961.42 to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets (30-count units) on November 13, 2025, with an ultimate completion date of November 14, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being fulfilled at the contractor's Conshohocken, Pennsylvania facility. The award represents a child contract under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a $12.76K delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Vemlidy 25 mg tablets in quantities of 30 units. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of November 14, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. Vemlidy is an antiviral medication used in the treatment of chronic hepatitis B, representing the type of specialized...
- The Defense Logistics Agency awarded a delivery order valued at $5,673.10 to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (30-count units) on July 30, 2025, with an ultimate completion date of July 31, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under an indefinite delivery contract vehicle. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Vemlidy is an antiviral medication...
- SPE2DR25D1053Indefinite Delivery Contract
- SPE2DR25D1053-SPE2DR26FT957Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets in a quantity of 30 units, valued at $20,868.93. This is a firm fixed price delivery order with no set-aside designation, issued on November 17, 2025, with an ultimate completion date of November 18, 2025. The work will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at approximately $1 billion and extends through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor that supplies comprehensive pharmaceutical products and medical supplies to support military and veteran healthcare systems. The company has demonstrated capability to meet federal procurement requirements through competitive award processes, serving customers including the Defense Health Agency and the U.S. Coast Guard. Vemlidy is an antiviral medication used in the treatment of chronic hepatitis B, representing the type of specialized pharmaceutical commodity that AmerisourceBergen routinely delivers under its expansive DLA contract vehicle to support military healthcare needs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $20.9k | 11/17/25 |